Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Date of authorisation: 27/04/2001, Revision: 35, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 7 November 2025 - 15:00

Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Date of authorisation: 27/04/2001, Revision: 35, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/hbvaxpro

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters